Home > Products > CD55 & HLA-A
> Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Fv-IgG) (CAT#: BSDG-124)
Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD55 IgG with similar domains from an anti-HLA-A antibody via short peptide linkers, or vice versa. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
HLA-A; major histocompatibility complex, class I, A; HLAA; HLA class I histocompatibility antigen, A-1 alpha chain; antigen presenting molecule; leukocyte antigen class I-A; MHC class I antigen HLA-A heavy chain
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Fv-IgG) (BSDG-124). Click the button below to contact us or submit your feedback about this product.